Mi­cro­cap Aridis re­cruits Take­da vet Paul Mendel­man to steer late-stage an­ti­body pro­grams in in­fec­tious dis­eases

A month ago one of Aridis Phar­ma’s an­ti-in­fec­tive an­ti­bod­ies flunked a Phase II test in ven­ti­la­tor-as­so­ci­at­ed pneu­mo­nia, forc­ing the team to aban­don the pro­gram but …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER